Stay updated on Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.

Latest updates to the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a system-level version update and does not alter study content.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedPadua, Italy 35128 was removed from the locations and Padova, Italy 35128 was added to the locations.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a frontend build/version change with no visible alterations to study details, eligibility criteria, or results on the page.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.4.3 implemented, replacing the previous v3.4.2.SummaryDifference0.0%

- Check68 days agoChange DetectedA new revision label v3.4.2 was added and the previous v3.4.1 revision was removed, indicating an administrative update to study documents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.